IUGR pups showed significantly higher total plasma amino acid levels at birth, compared to control pups of normal body size, with particular increases in gluconeogenic amino acids (alanine, glycine, proline, and valine). A fall to low levels of circulating amino acids was observed at 2-4 hr in the untreated progeny, coincident with the development of hypoglycemia. The group administered corticosteroids prenatally had more pronounced increases of plasma gluconeogenic amino acids than untreated animals, with alanine especially elevated. Despite 3-fold greater apparent utilization in animals administered glucocorticoid prenatally, high alanine levels were maintained in the treated dysmature group; a similar pattern was noted for glutamine-glutamate. In addition, an inverse correlation between plasma glucose at birth and plasma alanine levels was noted for all animals ( r = -0.55, P = 0.01), as well as an inverse correlation between plasma glucose and the four gluconeogenic amino acids (r = -0.62, P = 0.001).
Thus, the reduced tendency to develop hypoglycemia in corticosteroid-treated dysmaturc rat pups seems to be associated with both greater availability and increased utilization of glucogeneic amino acids. We therefore postulate that the hormone may act both to increase the supply of gluconeogenic substrate and to stimulate enzymes csscntial for gluconeogenesis.
INTRODUCTION RESULTS
Cystic Fibrosis is an sutosomal recessive condition characterized by malfunction of exocrine tissues (7) . The genetic defect in this disease has not been determined to date. Several recent reports have suggested the involvement of proteolytic enzymes in the disease process (10, 12, (14) (15) (16) (17) . Other investigators have demonstrated the presence in CF serum of a low molecular weight basic protein (3,s-10) . This protein had the capacity to disorganize rhythmic beating of the cilia. It was later found that the action of this factor could be destroyed by treatment with the enzyme eerbaxypeptidase (10) . This suggested the presence of functionally important arginine residues in the protein. These data correlate well with recent reports by Nadler and his associaten who have postulated a role for an erginine-esterolytio enzyme in the pathology of this disease (14) (15) (16) (17) . The enzyme, arginine esterase, is active with the synthetic substrate a-N-benzoyl-L-arginine ethyl ester (BAEE). Multiple forms of this enzyme have been shown in human plasma by means of ion exchange chromatography, isoelectric focusing on polyacrylamide gels and by inhibition with soybean trypsin inhibitor. Rao end Nadler (14) (15) (16) found that in plasma from CF patients there was an almost total deficiency of the srginine esterase activity susceptible to inhibition by soybean trypsin inhibitor. In a more recent report, these authors confirmed a deficiency of arginine esterase in CF plasma compared to controls with protmine as substrate (15) . In the present study, we have measured the activity of arginine esteralytie and other hydrolytic enzymes in liver to determine if the deficiency of arginine esterase observed in plasma and saliva wae aleo generally true in other tissues. A preliminary communication of this work has been published (6).
METHODS AND lNATERIALS CASE MATERIAL
Liver was obtained from two CF patients NL (male, 25 years, number 1 in Table 1 ) and BY (female, 19 years, number 2 in Table 1 ) . Both had been investigated in this hospital for many years. NL was diagnosed at age 2 and recent history included respiratory failure. At post mortem, there was extensive bronchiectasis, hepatomegaly, splenomegaly, right ventricular hypertrophy and a fibrotic pancreas with no cysts. Liver function tests were normal. The liver was obtained 19 h after death.
BY from a family of five siblings, four of whom have documented Cystic Fibrosis, was diagnosed at the age of 8 years. Her clinical course was chsracterized by recurrent respiratory infections. She developed cor pulmonale and an her terminal admission sustained three cardiac arrests, the lest of which was fatal. There was fibrosis of the pancreas with cysts and with destruction of exocrine tissue. A severe bronchiectasis was found and the liver did not show longstanding passive congestion. The liver was taken 5 hours after death.
Control specimens were from patients who died at the age of 8,15 and 18 years who had no evidence of liver dysfunction. The patient with Type I, G M~-gangliosidosis died at the age of 2 years while the patient with Gaucher disease died at 8 years. Lipid storage and enzymopathies have been confirmed in the latter two cases.
MATERIALS
Hemoglobin (Type 1, bovine blood), Fast Garnet-GBC salt, p-tosyl-L-arginine methyl ester -HCL (TAME), N-Carbabenzoxy-a-L-glutamyl-L-tyrosine, bovine serum albumin, ~enzo~lar~inine-6-naphthylamide (BANA) Soybean trypsin inhibitor (type 1 4 , lot 85C-8055, with a stated potency of 1 mgf1.6 mg Trypsin), (23) , N-Benzoyl-arginine ethyl ester (BAEE, lot 072074) (24) and lyophilized Trypsin (198 unitslmg) (25) were obtained comnercially.
TISSUE EXTRACTION
No specimens had been stored longer than 12 months. All tissues were frozen at -20'~ until processed. Several specimens from each tissue (0.5-0.7 g) were taken over several months. The samples were minced with scissors and homogenized in 10 volumes of 0.05 M sodium acetate-acetic acid buffer containing 1 mM EDTA and 0.154 M sodium chloride (final pH 4.6).
The extract was centrifuged at 31.500 g for 30 min. at 2 ' in a Beckman 5-21 centrifuge. The supernatant fluids were then stored at -20' until processed. ENZYME ASSAY Cathepsin A was measured with N-CBZ-glutamyl-tyrasine substrate while cathepsin D was measured with acid denatured hemoglobin (11) . Cathepsin B, was assayed with BANA substrate according to Barrett (2) . Arginine esterase was measured by two methods. The first according to Rao and Nadler (16) was modified as fallows: each quartz euvette ( 1 cm light path) contained in 1 ml final volume, 100 woles Tris-HC1 pH 9.0 and 0.5 voles BAEE. The reaction was started by addition of the enzyme extract after a 5 minute pre-incubation period. The temperature of the cuvettes was maintained at 37.0 * 0.5'~ by eirculating water from a Lauda K-2 thermostat. The initial velocities were calculated from the slope of the line measured at 253 m. aver the first 3-5 minutes. The second aasay for arginine esterase utiliz,ed the TAME substrate according to Siegelman s. (20) The glycosidases, a-mennosidase, a-fucosidase and 8-hexosaminidase were assayed according to Thomas pl (21) while (+,,l-ganglioside 8-galactosidase was assayed according to Callahan and Gerrie (4) . Sphingomyelinase was assayed according to the method of Schneider and Kennedy (19) . Protein meaeurements were made with bovine serum albumin as standard according to the method of Lowry g &. (13) Assays performed to determine the total activities of the various hydrolases in the liver extracts were carried out at five protein concentrations at a single time point. The progress of the reactions with time was linear in every instance. The units of activity and specific activities are defined in the legend to Table 1 .
ISOELECTRIC FOCUSING
Isoelectric focusing was carried out as described previously (5) . Briefly, tissues 0.5 -0.7 g were minced with scissors and homogenized in 10 vol 0.05 M sodium acetate-acetic acid buffer containing 1mM EDTA (final pH 4.6). 'The extract was centrifuged as above and the resulting fluids were exposed to current for 40-44 hours in a thermostatically controlled column. The experiment was carried out in the presence of sucrose gradients with 1% carrier ampholines, pH range 4-7. At the end of the experiment the column was eluted fran below and the eluates were collected in 0.8 -1.0 ml fractions. All eluates were kept at 4 ' C until analyzed. All enzymes were assayed in the presence of carrier ampholines and sucrose.
Liver samples from the two controls, the two CF patients, and single cases of CHI-gangliosidosis and Gaucher Disease were examined (Table 1 ) . In the liver of one CF patient the total activities of all enzymes were within control values. All enzyme activities were elevated in the liver from the second CF patient except for B-hexosaminidase, a-msnnosidase and a-fucosidase. The elevations seen in the lysosomal hydrolases measured in liver €ran Gaucher Disease and &I-gangliosidosis are consistent with previously published data (22) .
Cathepsin B1 was found to have a maximum activity at pH 6.4 in bath normal liver and in liver f r w patients with Cystic Fibrosis. The activity in the presence of cysteine was higher then the activity in its absence in all buffers tested and throughout the pH range (Fig. 1 ) . There was no difference in the Km or Vmax values for cathepsin B1 in normal and Cystic Fibrosis liver (Table 2 ) . Soybean trypsin inhibitor was tested for its effect on the activity of cathepsin B1. No inhibition of cathepsin B1 activity could be demonstrated over the range of 5-100 pg. Under the same conditions trypsin ( 1 pg) was completely inhibited at the level of 6 pg.
There was no difference in the level of arginine esterese between three normal controls and the liver samples from patients with Gaucher Disease and (+.,l-gangliosidaais (Table 3 ) . On the other hand, with BAEE there was a 50 per cent decrease in the total level of arginine esterase in the two patients with Cystic Fibrosis. With TAME as substrate however, there was little or no difference between the levels of the enzyme in the normal and the CF specimens. The Km and Vmax values for this enzyme were unchanged f r m normal ( Table 2 ) . The pH optimum of arginine esterase with both substrates was in the range of 8.5 -9.1 far both normal and CF liver specimens (Figure 2 ).
The effect of soybean trypsin inhibitor on liver arginine esterase activity was also examined. At concentrations of ST1 up to 100 pg, there waa little or no inhibition of arginine esterase activity in both normal liver and in liver from Cystic Fibrosis (Table 3) . Thus, the arginine esterase of liver is quite different in it. response to trypsin inhibitor from the enzyme found in plasma and saliva.
To identify the possible deficiency of one or more specific iso-enzymes, liver extracts were then subjected to isaeleetric focusing as described. Eluates were assayed for the presence of cathepsin B1, arginine esterase and for glycosidases. A single major peak of eethepsin B, was obtained (PI 4.9) in normal and CF liver (Figure 3 ) . Smaller amounts of activity were found at pI values below this isoelectric point. A small discrete peak of activity was also seen st pI 5.1 in both normaland in CF liver. Arginine esterase was measured in the eluates with BAEE as substrate. Two partially resolved peaks of activity were noted. The first had a pI in the range of 5.6-5.7 while the second had a p1 of 5.8-5.9. There was no difference in the activity profile of srginine esterase when assayed in the presence of 100 pg of soybean trypsin inhibitor. The recovery of cathepsin B1 activity was 37-47 for both normal and CF liver while arginine esterase recoveries were much better (67-75%). Glycosidases such as B-hexosaminidase, @-galactosidase and a-galactosaminidase were monitored as internal controls and were always normal.
DISCUSSION
The properties of cathespin B1 presented in this work (pH optimum, Km value, isoelectric point) confirm the findings of Barrett (2) and extend the data to include liver from Cystic Fibrosis patients. A previous report suggested the possibility that a carboxypeptidase or cathepsin B-like enzyme may be involved in CF (10, 17) . The present data seem to preclude a deficiency in Cathepsin B1 in Cystic Fibrosis. Other lysosomal hydrolases such as a-mannosidase, a-fucosidase, B-hexosaminidase, @-galactasidaee and sphingomyelinase gave normal or slightly elevated values with respect to total activity. Several isoelectric focusing experiments on liver extracts and also on extracts of cultured skin fibroblasts have shown a normal isoenzyme pattern for these hydrolases with the possible exception of a-fucosidase (unpublished observations: also see reference 1 ) .
Rao and Nadler have shown that arginine esterase of human plasma and saliva can be resolved into two separate peaks of activity by DEAE-cellulose chromatography (16) . The major enzyme is inhibited by trypsin inhibitor while the minor one is not. In liver, with both BAEE and TAME the pH optimum is more basic than for the enzyme in plasma and the liver enzyme is not inhibited by soybean trypsin inhibitor. However, preliminary experiments on the plasma enzyme with TAME as substrate have confirmed the presence of enzymes which can be activated by chloroform or elagic acid. Thus, it seems that the arginine esterase in liver is different from the majority of the enzyme in human plasma and saliva. It may be similar to or the s m e as the minor component which has been shown to be unaffected in CF (15, 16) .
The major component of plasma arginine esterase is presumed to be derived from the pancreas and other exocrine tiasues (18) . It would thus be of.interest to compare the levels of this enzyme in matched groups of CF patients, some of whom have marked pancreatic insufficiency and others who have normal or slightly altered pancreatic function. Such B study would show if the reduction in ST1 inhibitable arginine esterase activity observed in the studies of Rao and Nadler (14-17) was chiefly due to inadequate secretion of these enzymes by exocrine tissues.
In summary, we have examined Cathepsin B,, arginine esterase and other lysosomal hydralases in liver from control tissues and from patients with Cystic Fibrasis. We have not been able to detect any marked abnormalities in the properties or the isoenzyme distribution of any of these enzymes in Cystic Fibrosis liver. Since one would expect the genetic defect to be expressed in most if not all tissues, it is likely that the enzymes described here do not reflect the primary genetic defect in this disease. Soybean Trypsin Inhibitor (100 pg/ml) had no effect on the Arginine Esterase activity (solid circles). The pH (shown as a solid line) was measured in alternate fractions (0.8-1.0 ml). (8) substrates. In both sets of experiments two normal (solid symbols) end two CF livers (open symbols) were compared. In panel A, the buffers used were Tris-HC1 (circles) and Glycine-NaOH (triangles) while in panel 8, phoaphete buffer waa uaed from pH 6-8 and 2-mino-2-methyl-1: 3-propanediol-HCl buffer was employed frun pH 7.8-9.7. All points are averages of duplicate measurements.
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